Vanda Pharmaceuticals Inc (NASDAQ: VNDA) has acquired U.S. and Canadian rights to Ponvory (ponesimod) from Actelion Pharmaceuticals Ltd, a Johnson & Johnson company (NYSE:...
NEW YORK - Perrigo Co . (NYSE:PRGO) saw its shares decline by 1.43% to close at $30.91 on Tuesday, halting a three-day run of advances. The pharmaceutical company's stock is...
Johnson & Johnson (NYSE: JNJ) has no immediate plans to venture into weight-loss drugs due to the existing competition saturation, as Chief Executive Officer Joaquin...
Johnson & Johnson's (NYSE: JNJ) worldwide vice president for litigation, Erik Haas, disclosed recent settlements with several law firms regarding claims linking J&J talc products...
(Updated - December 5, 2023 12:14 PM EST) Investing.com – Main U.S. indexes were mixed on Tuesday. Data on job openings in October hinted at easing of labor demand, fueling hopes...
Johnson & Johnson (NYSE: JNJ) expects operational sales growth in the range of 5%-6% for FY24. The company forecasts adjusted operational earnings per share growth of 7.3% at the...
Johnson & Johnson’s stock JNJ was slightly higher premarket Tuesday, after the healthcare company set guidance for 2024 and for the longer term, ahead of an investor day at the New...
Johnson & Johnson (NYSE:JNJ) (the ‘Company’) is hosting a meeting today with the investment community at the New York Stock Exchange to present the Company’s overarching strategy,...